QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) CEO Discusses Personalized Immunotherapies in Interview on Uptick Newswire’s Stock Day Podcast
BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT) an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, was recently featured on Uptick Newswire’s Stock Day Podcast. Dr. Bill Williams, BriaCell’s president and CEO, was interviewed for the podcast by Everett Jolly of Stock Day. Per the interview, Dr. Williams expressed his enthusiasm regarding the company’s future, as he believes BriaCell is on the cutting edge of cancer treatment with its effective and safe immunotherapy applications. Williams also detailed BriaCell’s current major programs: Bria-IMT, which is in the clinic right now, and Bria-OTS, which is in development. “BriaCell is developing the…